Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Study Completion Date

May 31, 2009

Conditions

Healthy Subjects

Interventions

DRUG

AZD7295

ascending single doses (start dose 90 mg), oral solution and then multiple ascending dose (tbd based on single dose results), oral solution

DRUG

Placebo

multiple ascending dose (tbd based on single dose results), oral solution

Trial Locations (1)

Research Site, Fukuoka